← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Holding	Trade Value	Theme Stocks	% of Portfolio	Status
1	T. Rowe Price Associates Baltimore, Maryland	$9.58B	+$9.45B	17	2.56%	New
2	Fidelity Investments Boston, Massachusetts	$7.34B	+$7.16B	17	1.2%	New
3	Vanguard Group Malvern, Pennsylvania	$6.21B	+$6.1B	23	0.65%	New
4	Massachusetts Financial Services Boston, Massachusetts	$4.85B	+$4.75B	7	3.28%	New
5	State Street Boston, Massachusetts	$4.61B	+$4.56B	23	0.6%	New
6	Dodge & Cox San Francisco, California	$3.34B	+$3.43B	2	3.97%	New
7	BlackRock Institutional Trust San Francisco, California	$3.33B	+$3.27B	21	0.67%	New
8	Capital Research Global Investors Los Angeles, California	$2.57B	+$2.44B	5	1.09%	New
9	Wellington Management Group Boston, Massachusetts	$2.27B	+$2.28B	13	0.74%	New
10	Primecap Management Pasadena, California	$2.24B	+$2.28B	6	3.21%	New
11	Northern Trust Chicago, Illinois	$2.16B	+$2.13B	23	0.78%	New
12	Capital World Investors Los Angeles, California	$2.15B	+$2.21B	5	0.7%	New
13	Bank of New York Mellon New York	$1.86B	+$1.84B	23	0.58%	New
14	Morgan Stanley New York	$1.78B	+$1.69B	22	0.9%	New
15	BlackRock Fund Advisors San Francisco, California	$1.71B	+$1.67B	22	0.63%	New
16	Wells Fargo San Francisco, California	$1.57B	+$1.56B	22	0.81%	New
17	Viking Global Investors Stamford, Connecticut	$1.53B	+$1.5B	3	8.53%	New
18	JP Morgan Chase New York	$1.41B	+$1.42B	18	0.45%	New
19	Invesco Atlanta, Georgia	$1.37B	+$1.38B	18	0.64%	New
20	Goldman Sachs New York	$1.36B	+$1.37B	19	0.53%	New
21	Baillie Gifford & Co Edinburgh, United Kingdom	$1.3B	+$1.14B	6	3.93%	New
22	Neuberger Berman Group New York	$1.22B	+$1.21B	12	1.45%	New
23	Artisan Partners Milwaukee, Wisconsin	$1.19B	+$1.14B	5	2.56%	New
24	Norges Bank Oslo, Norway	$1.19B	+$1.18B	13	0.74%	New
25	Jennison Associates New York	$1.11B	+$1.02B	8	1.25%	New